A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III).
Ziai WC, McBee N, Lane K, Lees KR, Dawson J, Vespa P, Thompson RE, Mendelow AD, Kase CS, Carhuapoma JR, Thompson CB, Mayo SW, Reilly P, Janis S, Anderson CS, Harrigan MR, Camarata PJ, Caron JL, Zuccarello M, Awad IA, Hanley DF; MISTIE III Investigators.
Ziai WC, et al. Among authors: carhuapoma jr.
Int J Stroke. 2019 Jul;14(5):548-554. doi: 10.1177/1747493019839280. Epub 2019 Apr 3.
Int J Stroke. 2019.
PMID: 30943878
Free PMC article.
Clinical Trial.